Synergistic anti-tumor efficacy of doxorubicin and flavopiridol in an in vivo hepatocellular carcinoma model

被引：0
|
作者：
Min-Sun Kwak
Su Jong Yu
Jung-Hwan Yoon
Sung-Hee Lee
Soo-Mi Lee
Jeong-Hoon Lee
Yoon Jun Kim
Hyo-Suk Lee
Chung Yong Kim
机构：
[1] Seoul National University College of Medicine,Department of Internal Medicine and Liver Research Institute
[2] Seoul National University Hospital,Department of Internal Medicine, Healthcare Research Institute, Healthcare System Gangnam Center
来源：
Journal of Cancer Research and Clinical Oncology | 2015年 / 141卷
关键词：
Hepatocellular carcinoma; Doxorubicin; Flavopiridol; Apoptosis; Hypoxia;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2037 / 2045
页数：8
相关论文
共 50 条
  • [31] Enhanced anti-tumor efficacy of checkpoint inhibitors in combination with the histone deacetylase inhibitor Belinostat in a murine hepatocellular carcinoma model
    Diana Llopiz
    Marta Ruiz
    Lorea Villanueva
    Tamara Iglesias
    Leyre Silva
    Josune Egea
    Juan J. Lasarte
    Perrine Pivette
    Véronique Trochon-Joseph
    Bérangère Vasseur
    Graham Dixon
    Bruno Sangro
    Pablo Sarobe
    Cancer Immunology, Immunotherapy, 2019, 68 : 379 - 393
  • [32] Hexokinase-II Inhibition Synergistically Augments the Anti-tumor Efficacy of Sorafenib in Hepatocellular Carcinoma
    Yoo, Jeong-Ju
    Yu, Su Jong
    Na, Juri
    Kim, Kyungmin
    Cho, Young Youn
    Lee, Yun Bin
    Cho, Eun Ju
    Lee, Jeong-Hoon
    Kim, Yoon Jun
    Youn, Hyewon
    Yoon, Jung-Hwan
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (06)
  • [33] Anti-tumor efficacy of a recombinant human arginase in combination with chemotherapeutic agents in human hepatocellular carcinoma
    Chow, Ariel
    Pang, Roberta
    Chu, Andrew
    Ng, Lui
    Poon, Ronnie
    CANCER RESEARCH, 2011, 71
  • [34] Anti-tumor efficacy and safety of AEV01 in preclinical glioblastoma and hepatocellular carcinoma models
    Biswas, Indrani
    Precilla, Senthilathiban Daisy
    Kumar, Aravinda
    Sekhar, M. M.
    Medasani, Renu
    Anitha, T. S.
    SCIENTIFIC REPORTS, 2025, 15 (01):
  • [35] Anti-tumor therapy of glycyrrhetinic acid targeted liposome co-delivery of doxorubicin and berberine for hepatocellular carcinoma
    Xu, Na
    Wu, Jingliang
    Wang, Weihao
    Sun, Shujie
    Sun, Mengmeng
    Bian, Yandong
    Zhang, Huien
    Liu, Shuzhen
    Yu, Guohua
    DRUG DELIVERY AND TRANSLATIONAL RESEARCH, 2024, 14 (09) : 2386 - 2402
  • [36] Anti-tumor and anti-metastasis efficacy of a novel Notch inhibitor (PF-03084014) in hepatocellular carcinoma
    Wu Chuanxing
    Wang Xiaoqi
    CANCER RESEARCH, 2016, 76
  • [37] In vitro and in vivo synergistic anti-tumor efficacy of two naturally available dietary polyphenols EGCG and luteolin
    Amin, Arm
    Wang, Dongsheng
    Khuri, Fadlo
    Chen, Zhuo
    Shin, Dong
    CANCER RESEARCH, 2009, 69
  • [38] Comprehensive Analysis Identifies and Validates the Tumor Microenvironment Subtypes to Predict Anti-Tumor Therapy Efficacy in Hepatocellular Carcinoma
    Zhang, Haohan
    Yao, Yi
    Wu, Jie
    Zhou, Jin
    Zhao, Chen
    He, Junju
    Xu, Bin
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [39] Anti-tumor activity of KNTC2 siRNA in orthotopic tumor model mice of hepatocellular carcinoma
    Makita, Yukimasa
    Murata, Shumpei
    Katou, Yoshiki
    Kikuchi, Kuniko
    Uejima, Hiroshi
    Teratani, Mika
    Hoashi, Yasutaka
    Kenjo, Eriya
    Matsumoto, Satoru
    Nogami, Masahiro
    Otake, Kentaro
    Kawamata, Yuji
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2017, 493 (01) : 800 - 806
  • [40] SYNERGISTIC ANTI-TUMOR EFFECT OF ACTIVE IMMUOTHERAPY USING TUMOR LYSATE-PULSED DENDRITIC CELLS AND THYMOSIN α-1 IN A MURINE HEPATOCELLULAR CARCINOMA MODEL
    Kim, W.
    Kim, D.
    Jung, Y. J.
    JOURNAL OF HEPATOLOGY, 2012, 56 : S117 - S118
12345